HomeCRBP • NASDAQ
add
Corbus Pharmaceuticals Holdings Inc
Previous close
$6.96
Day range
$6.65 - $6.85
Year range
$6.65 - $61.90
Market cap
82.22M USD
Avg Volume
275.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.70M | 59.93% |
Net income | -13.78M | -37.10% |
Net profit margin | — | — |
Earnings per share | -1.15 | 49.34% |
EBITDA | -15.35M | -64.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 159.36M | 454.63% |
Total assets | 164.17M | 352.47% |
Total liabilities | 13.67M | -61.99% |
Total equity | 150.50M | — |
Shares outstanding | 12.18M | — |
Price to book | 0.56 | — |
Return on assets | -24.52% | — |
Return on capital | -26.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -13.78M | -37.10% |
Cash from operations | -13.94M | -94.29% |
Cash from investing | -15.36M | -241.00% |
Cash from financing | 25.04M | 3,150.43% |
Net change in cash | -4.26M | -247.00% |
Free cash flow | -9.28M | -416.99% |
About
Founded
Jan 1, 2009
Website
Employees
19
